Published in Curr Colorectal Cancer Rep on September 17, 2011
Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry. World J Gastroenterol (2014) 0.93
CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells. Radiother Oncol (2014) 0.88
Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication. PLoS One (2014) 0.83
Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line. Cancer Biol Ther (2012) 0.78
Oxidative stress induces the acquisition of cancer stem-like phenotype in breast cancer detectable by using a Sox2 regulatory region-2 (SRR2) reporter. Oncotarget (2016) 0.77
HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features. J Exp Clin Cancer Res (2017) 0.75
Lovastatin Decreases the Expression of CD133 and Influences the Differentiation Potential of Human Embryonic Stem Cells. Stem Cells Int (2016) 0.75
Polymorphisms of the Stem Cell Marker Gene CD133 and the Risk of Lung Cancer in Chinese Population. Lung (2016) 0.75
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2006) 24.52
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
Identification of pancreatic cancer stem cells. Cancer Res (2007) 18.36
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature (2005) 15.57
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell (2007) 14.87
Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res (2005) 13.89
Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A (2007) 13.58
Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell (2009) 12.96
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med (2004) 9.80
AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood (1997) 7.84
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell (2007) 7.05
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell (2010) 6.47
Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res (2009) 6.43
Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol (2008) 6.41
Glioblastoma stem-like cells give rise to tumour endothelium. Nature (2010) 6.18
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest (2008) 5.96
Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature (2008) 5.59
Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell (2010) 5.57
A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood (1997) 5.04
Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science (2006) 4.79
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A (2008) 4.60
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer (2011) 4.54
Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol (2011) 4.48
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A (2009) 4.19
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov (2009) 4.12
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene (2007) 3.96
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One (2009) 3.66
Generation of a prostate from a single adult stem cell. Nature (2008) 3.46
Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One (2008) 3.36
Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One (2008) 2.90
miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell (2010) 2.87
Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res (2008) 2.82
Prostate cancer stem cells: a new target for therapy. J Clin Oncol (2008) 2.71
Colon cancer stem cells: promise of targeted therapy. Gastroenterology (2010) 2.58
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res (2011) 2.50
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene (2008) 2.47
CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer (2008) 2.23
Recent advances in cancer stem cells. Curr Opin Genet Dev (2008) 2.17
Cancer stem cell niche: the place to be. Cancer Res (2011) 2.14
Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology (2008) 2.12
Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol (2009) 1.89
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer (2008) 1.75
The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells (2008) 1.70
Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells. Proc Natl Acad Sci U S A (2011) 1.68
Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proc Natl Acad Sci U S A (2010) 1.66
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells. Cancer Immunol Immunother (2009) 1.66
CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med (2008) 1.58
Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res (2008) 1.51
Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB. J Transl Med (2009) 1.48
Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res (2006) 1.47
Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. J Biol Chem (2009) 1.42
mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. Cancer Res (2009) 1.36
Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. Cancer Res (2008) 1.34
Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J Cell Sci (2004) 1.32
A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc Natl Acad Sci U S A (2011) 1.30
CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res (2010) 1.24
miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J Biol Chem (2010) 1.24
Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol (2006) 1.18
Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases. Clin Cancer Res (2006) 1.16
Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer (2007) 1.15
Prognostic value of CD133 expression in stage I lung adenocarcinomas. Int J Clin Exp Pathol (2010) 1.14
Selective localization of the polytopic membrane protein prominin in microvilli of epithelial cells - a combination of apical sorting and retention in plasma membrane protrusions. J Cell Sci (1999) 1.10
Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins. J Biol Chem (2003) 1.09
Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Eur J Cancer (2009) 1.08
CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer. Eur J Cancer (2009) 1.08
Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab. Clin Cancer Res (2009) 1.07
CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. J Gastroenterol (2010) 1.04
Prognostic impact of CD133 expression in gastric carcinoma. Anticancer Res (2010) 1.04
Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution. Ann Surg Oncol (2011) 1.01
Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma. J Clin Pathol (2011) 1.00
Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma. Oncol Rep (2010) 0.99
Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer. Hum Pathol (2010) 0.97
CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients. Br J Cancer (2009) 0.96
Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer. Anticancer Res (2011) 0.91
Stem cell marker prominin-1 regulates branching morphogenesis, but not regenerative capacity, in the mammary gland. Dev Dyn (2011) 0.89
Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery. Oncology (2010) 0.82
Perioperative tumor cell dissemination in patients with primary or metastatic colorectal cancer. Eur J Surg Oncol (2009) 0.79
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol (2005) 27.17
Identification of the haematopoietic stem cell niche and control of the niche size. Nature (2003) 18.17
Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature (2007) 14.28
T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity (2007) 13.29
Effectiveness of the global protected area network in representing species diversity. Nature (2004) 10.66
Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity (2008) 9.61
BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet (2004) 7.37
PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature (2006) 7.35
Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity (2009) 6.87
The stem cell niches in bone. J Clin Invest (2006) 4.11
PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet (2007) 4.09
Detection of functional haematopoietic stem cell niche using real-time imaging. Nature (2008) 4.06
CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol (2008) 3.51
Current view: intestinal stem cells and signaling. Gastroenterology (2008) 3.46
Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes. Cell Res (2006) 3.41
Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood (2002) 3.21
Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity (2010) 2.90
Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc Natl Acad Sci U S A (2009) 2.76
Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity (2010) 2.39
Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche. Cell (2012) 2.36
TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J Exp Med (2008) 2.33
Maternal imprinting at the H19-Igf2 locus maintains adult haematopoietic stem cell quiescence. Nature (2013) 2.22
Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol (2003) 2.12
Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ Res (2004) 2.10
Bone morphogenetic protein signaling inhibits hair follicle anagen induction by restricting epithelial stem/progenitor cell activation and expansion. Stem Cells (2006) 2.09
N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells. Cell Stem Cell (2008) 1.98
The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2003) 1.93
BMP signaling and stem cell regulation. Dev Biol (2005) 1.77
Bcl6 expression specifies the T follicular helper cell program in vivo. J Exp Med (2012) 1.69
Differential gene expression profiling of adult murine hematopoietic stem cells. Blood (2002) 1.69
Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by Akt. Proc Natl Acad Sci U S A (2004) 1.66
Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay. Gastroenterology (2013) 1.64
Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion. Genes Dev (2011) 1.63
A nomenclature for intestinal in vitro cultures. Am J Physiol Gastrointest Liver Physiol (2012) 1.61
Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis. Gastroenterology (2010) 1.57
Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool. Blood (2011) 1.54
Activated Notch4 inhibits angiogenesis: role of beta 1-integrin activation. Mol Cell Biol (2002) 1.52
Understanding hematopoietic stem-cell microenvironments. Trends Biochem Sci (2006) 1.48
Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice. Cancer Res (2007) 1.44
The Wnt antagonist Dkk1 regulates intestinal epithelial homeostasis and wound repair. Gastroenterology (2011) 1.39
Phospholemman modulates Na+/Ca2+ exchange in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol (2002) 1.36
Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer (2003) 1.36
Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. Birth Defects Res C Embryo Today (2010) 1.34
A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc Natl Acad Sci U S A (2011) 1.30
Disrupting the stem cell niche: good seeds in bad soil. Cell (2007) 1.23
Stem cell niche: microenvironment and beyond. J Biol Chem (2008) 1.22
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2006) 1.21
Bridging the BMP and Wnt pathways by PI3 kinase/Akt and 14-3-3zeta. Cell Cycle (2005) 1.20
Stem cells and their niche: an inseparable relationship. Development (2007) 1.20
Systems approaches to biology and disease enable translational systems medicine. Genomics Proteomics Bioinformatics (2012) 1.19
MicroRNA programs in normal and aberrant stem and progenitor cells. Genome Res (2011) 1.17
Brief report: CD24 and CD44 mark human intestinal epithelial cell populations with characteristics of active and facultative stem cells. Stem Cells (2013) 1.16
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys (2006) 1.16
Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis. Gastroenterology (2009) 1.15
Targeting stem cells-clinical implications for cancer therapy. Curr Stem Cell Res Ther (2009) 1.15
Cadherin-based adhesion is a potential target for niche manipulation to protect hematopoietic stem cells in adult bone marrow. Cell Stem Cell (2010) 1.14
Cutting edge: A critical role of B and T lymphocyte attenuator in peripheral T cell tolerance induction. J Immunol (2009) 1.10
JAM-A regulates epithelial proliferation through Akt/β-catenin signalling. EMBO Rep (2011) 1.07
Hypothermic protection of the ischemic heart via alterations in apoptotic pathways as assessed by gene array analysis. J Appl Physiol (1985) (2002) 1.03
Effects of Na(+)/Ca(2+) exchanger downregulation on contractility and [Ca(2+)](i) transients in adult rat myocytes. Am J Physiol Heart Circ Physiol (2002) 1.03
USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex. J Exp Med (2013) 1.02
Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents. J Control Release (2013) 1.01
Brief report: Dclk1 deletion in tuft cells results in impaired epithelial repair after radiation injury. Stem Cells (2014) 0.99
Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys (2009) 0.97
Quantitative proteomic analysis of metabolic regulation by copper ions in Methylococcus capsulatus (Bath). J Biol Chem (2004) 0.94
FGF signaling facilitates postinjury recovery of mouse hematopoietic system. Blood (2012) 0.92
5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells. Chin J Cancer (2010) 0.92
Cellular and molecular regulation of hematopoietic and intestinal stem cell behavior. Ann N Y Acad Sci (2005) 0.92
Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases. Am J Clin Oncol (2006) 0.90
Assembly of magnetic nanospheres into one-dimensional nanostructured carbon hybrid materials. Langmuir (2010) 0.89
Celecoxib downregulates CD133 expression through inhibition of the Wnt signaling pathway in colon cancer cells. Cancer Invest (2012) 0.88
A multicenter study to standardize reporting and analyses of fluorescence-activated cell-sorted murine intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2013) 0.88
Systems biology and cancer stem cells. J Cell Mol Med (2007) 0.88
Epigenetic regulation of wnt pathway antagonists in human glioblastoma multiforme. Genes Cancer (2010) 0.87
Inhibition of Notch signaling reduces the number of surviving Dclk1+ reserve crypt epithelial stem cells following radiation injury. Am J Physiol Gastrointest Liver Physiol (2013) 0.87
Recent advances in understanding extrinsic control of hematopoietic stem cell fate. Curr Opin Hematol (2006) 0.87
Shifting in balance between osteogenesis and adipogenesis substantially influences hematopoiesis. J Mol Cell Biol (2009) 0.85
Guanidine/Pd(OAc)2-catalyzed room temperature Suzuki cross-coupling reaction in aqueous media under aerobic conditions. J Org Chem (2007) 0.84
Inducible expression of Runx2 results in multiorgan abnormalities in mice. J Cell Biochem (2011) 0.84
Phase I adjuvant trial of sorafenib in patients with hepatocellular carcinoma after orthotopic liver transplantation. Anticancer Res (2013) 0.84
Immune-mediated signaling in intestinal goblet cells via PI3-kinase- and AKT-dependent pathways. Am J Physiol Gastrointest Liver Physiol (2008) 0.84
Abnormal Wnt signaling and stem cell activation in reactive lymphoid tissue and low-grade marginal zone lymphoma. Leuk Lymphoma (2010) 0.83
Rescue of contractile abnormalities by Na+/Ca2+ exchanger overexpression in postinfarction rat myocytes. J Appl Physiol (1985) (2002) 0.83
Molecular profiling of stem cells. Clin Chim Acta (2007) 0.83
Downregulation of angiogenin inhibits the growth and induces apoptosis in human bladder cancer cells through regulating AKT/mTOR signaling pathway. J Mol Histol (2015) 0.82
An epigenetic biomarker panel for glioblastoma multiforme personalized medicine through DNA methylation analysis of human embryonic stem cell-like signature. OMICS (2014) 0.81
Functional assays for hematopoietic stem cell self-renewal. Methods Mol Biol (2010) 0.80
Self-renewal versus transformation: Fbxw7 deletion leads to stem cell activation and leukemogenesis. Genes Dev (2008) 0.80
Quantitative proteomic approaches for biomarker discovery. Proteomics Clin Appl (2007) 0.79
Asymmetric phase-transfer catalysts bearing multiple hydrogen-bonding donors: highly efficient catalysts for enantio- and diastereoselective nitro-mannich reaction of amidosulfones. Org Lett (2014) 0.79
N-glycoproteome of E14.Tg2a mouse embryonic stem cells. PLoS One (2013) 0.79
Efficient one-pot synthesis of substituted pyridines through multicomponent reaction. Org Biomol Chem (2010) 0.79
A phase 2 trial of ixabepilone plus cetuximab in first-line treatment of metastatic pancreatic cancer. Gastrointest Cancer Res (2012) 0.78
Bilateral effects of 6 weeks' unilateral acupuncture and electroacupuncture on ankle dorsiflexors muscle strength: a pilot study. Arch Phys Med Rehabil (2011) 0.78
Quantitative Analysis of Bladder Wall Thickness for Magnetic Resonance Cystoscopy. IEEE Trans Biomed Eng (2015) 0.77
Effects of sprint training on contractility and [Ca(2+)](i) transients in adult rat myocytes. J Appl Physiol (1985) (2002) 0.77
Sinusoidal microcirculatory changes after small-for-size liver transplantation in rats. Transpl Int (2010) 0.77